Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Biotronik wins CE Mark for Magmaris bioresorbable scaffold
Biotronik said today it won CE Mark for its Magmaris magnesium bioresorbable scaffold designed to treat coronary artery disease.
Data from the Biosolve-II trial of the stent was previously published in The Lancet, the company said, and 1-year data examining the safety of the device was recently published in The European Heart Journal. Read more
4. Silk Road touts TCAR study data
Silk Road Medical disclosed encouraging new clinical data for its Enroute device, which is cleared to help protect the brain from stroke while implanting a transcarotid artery stent.
The company said that additional data showed its Enroute transcarotid neuroprotection and stent system, indicated for transcarotid artery revascularization (TCAR), helped improve stroke and death rates in the wake of its FDA sign-off last October. Investigators from Massachusetts General Hospital and elsewhere presented their findings during the 2016 Vascular Annual Meeting of the Society for Vascular Surgery, which was held June 8-11 in National Harbor, MD. Read more
3. Medtronic inks partnership deal with self-management program dev Canary Health
Medtronic is partnering with digital health self-management program developer Canary Health to resell and distribute its full suite of chronic disease self-management program, including its Diabetes Prevention Program.
Through the partnership, the 2 companies will also develop additional solutions that operate around Medtronic’s devices, services and infrastructure as well as Canary Health’s platform of behavior change programs. Read more
2. Nevro closes over-subscribed $173m round
Nevro Corp. said Monday it closed a $172.5 million round of financing, including a fully-exercised underwriter’s over-allotment option, through the sale of 1.75% convertible senior notes due 2021.
Funds raised in the round are slated to be used to pay for the net cost of convertible note hedge and warrant transactions from the offering, with $21 million earmarked to repay an existing term loan agreement with Capital Royalty Partners. Read more
1. Suit claims Intuitive’s da Vinci caused metallic microemboli in patient’s brains
A group of heart surgery patients are taking Intuitive Surgical to court, claiming its da Vinci surgical robot caused metallic debris to end up in their brains after mitral valve surgery.
The complaint was filed this week in Georgia’s Northern District Court. Read more
The post MassDevice.com +5 | The top 5 medtech stories for June 15, 2016 appeared first on MassDevice.
from MassDevice http://ift.tt/263lMDZ
Cap comentari:
Publica un comentari a l'entrada